It should be noted that there is no known relationship between asthma and male pattern baldness, and that the PGD2 works differently in the two areas of the body.
The enzymes that create PGD2 in the scalp come from the brain, and the PGD2 in the lungs which causes asthmatic reactions is blood-born. When an asthmatic comes in contact with an allergen trigger, the production
of PGD2 goes into overdrive, leads to inflammation of the bronchial tissues and causes the difficulty in breathing. There has been no evidence to link asthmatic reactions caused by the PGD2 creation triggered in
asthmatics with any hair loss in those individuals.
Unfortunately, there are factors that are still uncertain. There is no timetable for testing and trials of possible treatments. There are the factors of dosage and
safety issues to be considered – and approval to be obtained - before testing could be performed. There is also the question of whether or not the treatment would be merely a preventive. It may not work on men who
have already lost their hair. Even so, there is a great deal of hope to be had in the news that has been revealed in this research.